(3) Should invasive cancers with a HER2/chromosome enumeration probe (CEP17) ratio of ≥2.0 but an average HER2 copy number of <4.0 signals per cell be considered ISH positive (designated as ISH group 2)? The gene discussed is ERBB2; the disease is cancer.